URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Ekaterina Noyes

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentSurgery
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box SURG
Rochester NY 14642
Other Positions
TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentPublic Health Sciences

 
 Awards And Honors
1994 - 1995Russian Presidential Scholarship for Research Abroad
1997     Graduate Student Society Travel Award for First-Time Presentation  | University of Rochester School of Medicine and Dentistry
2004     Best Podium Presentation  | International Society for Pharmacoeconomics & Outcomes Research
2004     Excellence in Research Incentive Award  | University of Rochester Medical School
2005     Best Short Course Presentation  | Society for Medical Decision Making 27th Annual Meeting
2007     Dean's Teaching Fellowship  | University of Rochester School of Medicine and Dentistry
2011     Best Poster Award  | International Society for Pharmacoeconomics and Outcomes Researc
 
 Overview
Dr. Noyes is Professor of Surgery and Public Health Sciences and Scientific Director of Surgical Health Outcomes and Research Enterprise (SHORE). She is a health services researcher with expertise in quality of care assessment, comparative effectiveness, and health outcomes and economic evaluations in healthcare. She is co-Director of Comparative Effectiveness Research (CER) Key Function Committee for the University of Rochester Clinical and Translation Science Institute, and co-Director of Center for Research Implementation and Translation (CRIT) at the URMC. Dr. Noyes has extensive experience working with interdisciplinary research teams on projects involving program evaluation, healthcare delivery and public health organizations funded by the NIH, AHRQ and other public and private sources. She has over 50 publications on quality measures, reimbursement, and cost-effectiveness of medical care. Dr. Noyes is has been involved in and led studies on evaluation of quality of life, cost and quality of long-term interventions, including cost-effectiveness of treatment for bladder, breast, and colorectal cancer, Parkinson's disease, and multiple sclerosis, use of implantable cardiac defibrillators, telemedicine, and effect of frailty on costs and quality of care.

 
 Selected Publications
List All   |   Timeline
  1. Kaldate R, Huston A, McCoy H, Cardeiro D, Noyes K. Cost Effectiveness Analysis of Genetic Testing for Breast and Ovarian Cancer Susceptibility Genes: BRCA1 and BRCA2. Breast J. 2014 May; 20(3):325-6.
    View in: PubMed
  2. Noyes K, Weinstock-Guttman B. Impact of diagnosis and early treatment on the course of multiple sclerosis. Am J Manag Care. 2013 Nov; 19(17 Suppl):s321-31.
    View in: PubMed
  3. Iannuzzi JC, Rickles AS, Kelly KN, Fleming FJ, Dolan JG, Monson JR, Noyes K. Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery. J Gastrointest Surg. 2014 Jan; 18(1):60-8.
    View in: PubMed
  4. Rickles AS, Iannuzzi JC, Kelly KN, Cooney RN, Brown DA, Davidson M, Hellenthal N, Max C, Johnson J, Detraglia J, McGurrin M, Kimball R, Dibenedetto A, Galyon D, Esposito SL, Noyes K, Monson JR, Fleming FJ. Anastomotic leak or organ space surgical site infection: What are we missing in our quality improvement programs? Surgery. 2013 Oct; 154(4):680-9.
    View in: PubMed
  5. Noyes K, Bajorska A, Weinstock-Guttman B, Mukamel DB. Is There Extra Cost of Institutional Care for MS Patients? Mult Scler Int. 2013; 2013:713627.
    View in: PubMed
  6. Thompson JP, Abdolahi A, Noyes K. Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider. Pharmacoeconomics. 2013 Jun; 31(6):455-69.
    View in: PubMed
  7. Noyes K, Bajorska A, Fisher S, Sauer J, Fagnano M, Halterman JS. Cost-Effectiveness of the School-Based Asthma Therapy (SBAT) Program. Pediatrics. 2013 Mar; 131(3):e709-17.
    View in: PubMed
  8. Hettinger AZ, Cushman JT, Shah MN, Noyes K. Emergency medical dispatch codes association with emergency department outcomes. Prehosp Emerg Care. 2013 Jan-Mar; 17(1):29-37.
    View in: PubMed
  9. Veazie PJ, Noyes K, Li Q, Hall WJ, Buttaccio A, Thevenet-Morrison K, Moss AJ. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure. J Am Coll Cardiol. 2012 Nov 6; 60(19):1940-4.
    View in: PubMed
  10. Shprecher D, Noyes K, Biglan K, Wang D, Dorsey ER, Kurlan R, Adams MJ. Willingness of Parkinson's disease patients to participate in research using internet-based technology. Telemed J E Health. 2012 Nov; 18(9):684-7.
    View in: PubMed
  11. Noyes K, Veazie P, Hall WJ, Zhao H, Buttaccio A, Thevenet-Morrison K, Moss AJ. Cost-Effectiveness of Cardiac Resynchronization Therapy in the MADIT-CRT Trial. J Cardiovasc Electrophysiol. 2013 Jan; 24(1):66-74.
    View in: PubMed
  12. Fan L, Mohile S, Zhang N, Fiscella K, Noyes K. Self-reported cancer screening among elderly Medicare beneficiaries: a rural-urban comparison. J Rural Health. 2012; 28(3):312-9.
    View in: PubMed
  13. Heatwole C, Johnson N, Holloway R, Noyes K. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study. J Clin Neuromuscul Dis. 2011 Dec; 13(2):85-94.
    View in: PubMed
  14. Noyes K, Liu H, Lyness JM, Friedman B. Medicare beneficiaries with depression: comparing diagnoses in claims data with the results of screening. Psychiatr Serv. 2011 Oct; 62(10):1159-66.
    View in: PubMed
  15. Noyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, Holloway RG, Dick AW. Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology. 2011 Jul 26; 77(4):355-63.
    View in: PubMed
  16. Xian Y, Holloway RG, Noyes K, Shah MN, Friedman B. Racial differences in mortality among patients with acute ischemic stroke: an observational study. Ann Intern Med. 2011 Feb 1; 154(3):152-9.
    View in: PubMed
  17. Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011 Jan 26; 305(4):373-80.
    View in: PubMed
  18. Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview. Urol Oncol. 2012 Mar-Apr; 30(2):126-32.
    View in: PubMed
  19. Ruan S, Noyes K, Bazarian JJ. The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury. J Neurotrauma. 2009 Oct; 26(10):1655-64.
    View in: PubMed
  20. Madeb R, Golijanin D, Noyes K, Fisher S, Stephenson JJ, Long SR, Knopf J, Lyman GH, Messing EM. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer. 2009 Jun 15; 115(12):2660-70.
    View in: PubMed
  21. McConnochie KM, Wood NE, Herendeen NE, Ng PK, Noyes K, Wang H, Roghmann KJ. Acute illness care patterns change with use of telemedicine. Pediatrics. 2009 Jun; 123(6):e989-95.
    View in: PubMed
  22. Liu H, Phelps CE, Veazie PJ, Dick AW, Klein JD, Shone LP, Noyes K, Szilagyi PG. Managed care quality of care and plan choice in New York SCHIP. Health Serv Res. 2009 Jun; 44(3):843-61.
    View in: PubMed
  23. Noyes K, Corona E, Veazie P, Dick AW, Zhao H, Moss AJ. Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs. 2009; 9(6):393-400.
    View in: PubMed
  24. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009 Jan 1; 115(1):68-74.
    View in: PubMed
  25. Noyes K, Liu H, Temkin-Greener H. Medicare capitation model, functional status, and multiple comorbidities: model accuracy. Am J Manag Care. 2008 Oct; 14(10):679-90.
    View in: PubMed
  26. Noyes K, Singer EA, Messing EM. Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors. Curr Opin Urol. 2008 Sep; 18(5):533-9.
    View in: PubMed
  27. Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG. Quantitative risk-benefit analysis of natalizumab. Neurology. 2008 Jul 29; 71(5):357-64.
    View in: PubMed
  28. Holland ML, Huston A, Noyes K. Cost-effectiveness of testing for breast cancer susceptibility genes. Value Health. 2009 Mar-Apr; 12(2):207-16.
    View in: PubMed
  29. O'Connor AB, Noyes K, Holloway RG. A cost-utility comparison of four first-line medications in painful diabetic neuropathy. Pharmacoeconomics. 2008; 26(12):1045-64.
    View in: PubMed
  30. Bonafede M, Dick A, Noyes K, Klein JD, Brown T. The effect of acupuncture utilization on healthcare utilization. Med Care. 2008 Jan; 46(1):41-8.
    View in: PubMed
  31. O'Connor AB, Noyes K, Holloway RG. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. J Am Geriatr Soc. 2007 Aug; 55(8):1176-84.
    View in: PubMed
  32. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007 Aug; 18(8):833-8.
    View in: PubMed
  33. Noyes K, Dick AW, Holloway RG. The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation. Med Decis Making. 2007 May-Jun; 27(3):327-34.
    View in: PubMed
  34. Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, Moss AJ, Dick AW. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007 May; 45(5):377-85.
    View in: PubMed
  35. Dorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR. Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis. Neurology. 2007 May 1; 68(18):1524-8.
    View in: PubMed
  36. Noyes K, Liu H, Holloway R, Dick AW. Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord. 2007 Mar 15; 22(4):509-14.
    View in: PubMed
  37. Piotrowicz K, Noyes K, Lyness JM, McNitt S, Andrews ML, Dick A, Hall WJ, Moss AJ, Zareba W. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur Heart J. 2007 Mar; 28(5):601-7.
    View in: PubMed
  38. Noyes K, Liu H, Temkin-Greener H. Cost of caring for Medicare beneficiaries with Parkinson's disease: impact of the CMS-HCC risk-adjustment model. Dis Manag. 2006 Dec; 9(6):339-48.
    View in: PubMed
  39. Noyes K, Liu H, Holloway RG. What is the risk of developing parkinsonism following neuroleptic use? Neurology. 2006 Mar 28; 66(6):941-3.
    View in: PubMed
  40. Noyes K, Liu H, Li Y, Holloway R, Dick AW. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord. 2006 Mar; 21(3):362-72.
    View in: PubMed
  41. Noyes K, Dick AW, Holloway RG. Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health. 2006 Jan-Feb; 9(1):28-38.
    View in: PubMed
  42. Noyes K, Dick AW, Holloway RG. Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness. Pharmacoeconomics. 2005; 23(12):1257-70.
    View in: PubMed
  43. Noyes K, Dick AW, Holloway RG. Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial. Med Decis Making. 2004 Sep-Oct; 24(5):472-85.
    View in: PubMed
  44. Holloway R, Nesbit K, Bordley D, Noyes K. Teaching and evaluating first and second year medical students' practice of evidence-based medicine. Med Educ. 2004 Aug; 38(8):868-78.
    View in: PubMed
  45. Noyes K, Holloway RG. Evidence from cost-effectiveness research. NeuroRx. 2004 Jul; 1(3):348-55.
    View in: PubMed
  46. Custer AW, Kazarinova-Noyes K, Sakurai T, Xu X, Simon W, Grumet M, Shrager P. The role of the ankyrin-binding protein NrCAM in node of Ranvier formation. J Neurosci. 2003 Nov 5; 23(31):10032-9.
    View in: PubMed
  47. Chen C, Bharucha V, Chen Y, Westenbroek RE, Brown A, Malhotra JD, Jones D, Avery C, Gillespie PJ, Kazen-Gillespie KA, Kazarinova-Noyes K, Shrager P, Saunders TL, Macdonald RL, Ransom BR, Scheuer T, Catterall WA, Isom LL. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):17072-7.
    View in: PubMed
  48. Kazarinova-Noyes K, Shrager P. Molecular constituents of the node of Ranvier. Mol Neurobiol. 2002 Oct-Dec; 26(2-3):167-82.
    View in: PubMed
  49. Kazarinova-Noyes K, Malhotra JD, McEwen DP, Mattei LN, Berglund EO, Ranscht B, Levinson SR, Schachner M, Shrager P, Isom LL, Xiao ZC. Contactin associates with Na+ channels and increases their functional expression. J Neurosci. 2001 Oct 1; 21(19):7517-25.
    View in: PubMed
  50. Shrager P, Custer AW, Kazarinova K, Rasband MN, Mattson D. Nerve conduction block by nitric oxide that is mediated by the axonal environment. J Neurophysiol. 1998 Feb; 79(2):529-36.
    View in: PubMed

Visualizations


Noyes's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department